The FDA has approved the first proteolysis-targeting chimera for any oncologic indication. Vepdegestrant (Veppanu, Arvinas ...

Most patients with systemic sclerosis require treatment with multiple modes of action, according to a presenter at Congress ...

In 2026, the biggest drivers of market trends in ophthalmology include rare diseases as well as gene therapies and AI, ...

Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...

BillionToOne, a molecular diagnostics company, announced the launch of a noninvasive test for pregnancies with high fetal ...

Nearly one-third of children with autism were diagnosed by a primary care provider, according to a study of Medicaid data ...

Since we have not addressed estate planning in this column for years, we wanted to dedicate another installment on it.

Certain demographic and socioeconomic factors were associated with no-show rates for dermatology appointments, according to a ...

Nicole B. Saphier, MD, has replaced Casey Means, MD, as the president’s nominee for surgeon general after months of a stalled ...

Having a birth plan in place was associated with improved maternal and neonatal outcomes, according to research presented at ...

Digital eyestrain or computer vision syndrome is real, increasing in prevalence and severity, and is a causative factor in ...

Non-tobacco nicotine use before a positive pregnancy result increased the risk for pregnancy and delivery complications, ...